MedPath
NMPA Approval

人参再造丸

国药准字Z15021703

April 24, 2020

Drug Information

人参再造丸

丸剂(大蜜丸)

每丸重3g

中药

April 24, 2020

Company Information

Applicant Company

Manufacturing Company

巴彦淖尔经济开发区东区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

人参再造丸 - NMPA 批准文号 | MedPath